Effects of Subcutaneous Glucagon-Like Peptide 1 (GLP-1 [7-36 Amide]) in Patients With NIDDM
Diabetologia - Germany
doi 10.1007/s001250050613
Full Text
Open PDFAbstract
Available in full text
Date
November 21, 1996
Authors
Publisher
Springer Science and Business Media LLC